v1
Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients.
Identifier:nobleid.org/w1/20260515/CF2CD240
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CF2CD240)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →